Regulatory Status and Timeline As of March 2026, retatrutide has not received FDA approval or approval by any other regulatory agency
Quinidine, disopyramide, and procainamide are used in the management of supraventricular tachyarrhythmias, recurrent atrial fibrillation, ventricular tachycardia, ventricular fibrillation, Brugada syndrome, and Short QT Syndrome (SQTS) (4)
Growing smartphone usage and online pharmacy adoption are improving availability of protein, hydration, and metabolic-health supplements across urban populations
Running out and then waiting for delivery creates pressure to use potentially degraded medication
2011 Oct;31(7):1079-88
DeRosier F, Hibbs C, Alessi K et al (2024) Progressive supranuclear palsy: neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies